Literature DB >> 7651893

Modulation of preproenkephalin mRNA levels in brain regions and spinal cord of rats treated chronically with morphine.

K P Gudehithlu1, H N Bhargava.   

Abstract

The effect of morphine tolerance/dependence and abstinence on the preproenkephalin (PPE) gene expression was determined in brain regions and spinal cord of the rat. Male Sprague-Dawley rats were rendered tolerant and physically dependent on morphine by SC implantation of six pellets, each containing 75 mg of morphine base, during a 7-day period. Placebo pellet-implanted rats served as controls. In tolerant rats, the pellets were left in place at the time of sacrifice whereas in abstinent rats, the pellets were removed 16 h prior to sacrificing. The levels of PPE mRNA were determined in brain regions (striatum, cortex, pons-medulla, hypothalamus, amygdala, and midbrain) and spinal cord. The levels of PPE mRNA increased significantly in the cortex (62%) and the spinal cord (352%) of morphine-tolerant rats when compared to placebo pellet-implanted control rats. In other brain regions, the levels of PPE mRNA in placebo and morphine-tolerant rats did not differ. On the other hand, in morphine-abstinent rats, the levels of PPE mRNA increased in the striatum (62%) and hypothalamus (34%) but were decreased in pons-medulla (68%), midbrain (51%), and spinal cord (36%) in comparison to the placebo controls. The results clearly demonstrate differential changes in enkephalin gene expression in brain regions and spinal cord of the abstinent and nonabstinent morphine-tolerant/dependent rats.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7651893     DOI: 10.1016/0196-9781(94)00199-g

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  5 in total

1.  Peptidomics of Cpefat/fat mouse hypothalamus and striatum: effect of chronic morphine administration.

Authors:  Fabien M Décaillot; Fa-Yun Che; Lloyd D Fricker; Lakshmi A Devi
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

2.  Regional mRNA expression of the endogenous opioid and dopaminergic systems in brains of C57BL/6J and 129P3/J mice: strain and heroin effects.

Authors:  S D Schlussman; J Cassin; Y Zhang; O Levran; A Ho; M J Kreek
Journal:  Pharmacol Biochem Behav       Date:  2011-07-23       Impact factor: 3.533

Review 3.  Neuroadaptive responses in brainstem noradrenergic nuclei following chronic morphine exposure.

Authors:  E J Van Bockstaele; A S Menko; G Drolet
Journal:  Mol Neurobiol       Date:  2001 Apr-Jun       Impact factor: 5.590

4.  Tolerance develops in spinal cord, but not in brain with chronic [Dmt1]DALDA treatment.

Authors:  Yong Ben; Andrew P Smith; Peter W Schiller; Nancy M Lee
Journal:  Br J Pharmacol       Date:  2004-11-22       Impact factor: 8.739

Review 5.  Reward processing by the opioid system in the brain.

Authors:  Julie Le Merrer; Jérôme A J Becker; Katia Befort; Brigitte L Kieffer
Journal:  Physiol Rev       Date:  2009-10       Impact factor: 37.312

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.